Nelson, Van Denburg & Campbell Wealth Management Group, LLC Horizon Therapeutics Public LTD CO Transaction History

Nelson, Van Denburg & Campbell Wealth Management Group, LLC

$2.1 Billion
Q1 2024

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	SELL	$107.32 - $113.5 $275,919 - $291,808	-2,571 Reduced 96.26%	100 $10,000
Q1 2022 May 13, 2022	BUY	$86.42 - $109.81 $222,185 - $282,321	2,571 Added 2571.0%	2,671 $280,000
Q3 2021 Nov 02, 2021	SELL	$91.91 - $110.37 $316,078 - $379,562	-3,439 Reduced 97.17%	100 $10,000
Q2 2021 Jul 27, 2021	SELL	$86.24 - $95.92 $438,702 - $487,945	-5,087 Reduced 58.97%	3,539 $331,000
Q1 2021 May 11, 2021	SELL	$71.83 - $95.48 $143,947 - $191,341	-2,004 Reduced 18.85%	8,626 $793,000

Q4 2020 Feb 09, 2021	BUY	$67.0 - $84.39 $712,210 - $897,065	10,630 New	10,630 $777,000

Others Institutions Holding HZNP

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

20K

View Full List

About Horizon Therapeutics Public Ltd Co

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

More about HZNP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nelson, Van Denburg & Campbell Wealth Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nelson, Van Denburg & Campbell Wealth Management Group, LLC with notifications on news.

Account